Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Nano-engineering the titanium-tissue interface: a 15 year perspective on bio-functionalization and surface innovation

Savargaonkar AV., Singh R., Popat KC.

Narrative Review on Face & Skin, published in Nanoscale Adv (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Nanoscale Adv (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42281799
PMCID
PMC13251067
DOI
10.1039/d6na00117c

Abstract (original English)

Biofunctionalization of nanostructured titanium surfaces is a promising strategy to improve the performance of biomedical implants and devices. While titanium offers excellent mechanical properties and biocompatibility, it often encounters challenges such as bacterial infections, thrombogenicity, and complex cellular interactions. This review highlights decades of research in our laboratory on surface nanoengineering and biomaterial coating innovations that have significantly enhanced cellular adhesion, growth, and differentiation. Nanoengineered surfaces with adjustable wettability can significantly impact protein adsorption, cell adhesion, and blood compatibility. The potential of various biopolymer coatings, such as tanfloc, chitosan, heparin, and multilayer polyelectrolyte combinations, to promote beneficial cellular responses, support stem cell differentiation, and enhance hemocompatibility is also examined. Furthermore, the antimicrobial effects of these biopolymer-coated nanostructured titanium surfaces show promise in reducing infection risks associated with implants. Additionally, integrating small biomolecules, growth factors, and mineralization processes with relevant active metal ions reveals the potential of combining surface functionalization with nanoalteration. Finally, the review discusses current challenges and prospects in titanium implant surface engineering

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research